McCourt Marion
Insider CIK 1663758 · MDVN Chief Operating Officer · SCYX Director · CTMX Director · AXON Principal Operating Officer · REGN SVP Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-09-03 | 2026-09-03 | 1,131 | $857.39 | $969.7K | 12,003 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-09-03 | 2026-09-03 | 1,131 | $857.39 | $969.7K | 12,003 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-09-02 | 2026-09-03 | 1,215 | $850.00 | $1.03M | 13,134 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-09-02 | 2026-09-03 | 1,215 | $850.00 | $1.03M | 13,134 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-09 | 2025-12-11 | 1,021 | $701.51 | $716.2K | 14,349 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-08 | 2025-12-09 | 1,336 | $712.94 | $952.5K | 15,370 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-12-05 | 2025-12-09 | 12,210 | — | $0 | 12,210 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-12-05 | 2025-12-09 | 2,476 | — | $0 | 16,706 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-12-16 | 2024-12-18 | 759 | $730.81 | $554.7K | 14,230 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-10 | 274 | $787.00 | $215.6K | 14,989 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-12-06 | 2024-12-10 | 8,981 | — | $0 | 8,981 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-12-06 | 2024-12-10 | 2,332 | — | $0 | 15,263 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-11-01 | 2024-11-05 | 1,000 | — | $0 | 6,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-11-01 | 2024-11-05 | 1,000 | $381.40 | $381.4K | 13,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-11-01 | 2024-11-05 | 1,000 | $844.61 | $844.6K | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-10-01 | 2024-10-03 | 1,000 | — | $0 | 7,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-10-01 | 2024-10-03 | 1,000 | $381.40 | $381.4K | 13,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-10-01 | 2024-10-03 | 1,000 | $1054.06 | $1.05M | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-09-03 | 2024-09-05 | 1,000 | — | $0 | 8,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-09-03 | 2024-09-05 | 1,000 | $381.40 | $381.4K | 13,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-09-03 | 2024-09-05 | 1,000 | $1178.73 | $1.18M | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-08-01 | 2024-08-05 | 1,137 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-08-01 | 2024-08-05 | 1,137 | $1060.86 | $1.21M | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-08-01 | 2024-08-05 | 1,137 | $372.46 | $423.5K | 14,068 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-07-01 | 2024-07-02 | 1,137 | — | $0 | 1,137 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-07-01 | 2024-07-02 | 1,137 | $1047.11 | $1.19M | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-07-01 | 2024-07-02 | 1,137 | $372.46 | $423.5K | 14,068 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-06-03 | 2024-06-05 | 1,138 | — | $0 | 2,274 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-03 | 2024-06-05 | 1,138 | $980.16 | $1.12M | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-06-03 | 2024-06-05 | 1,138 | $372.46 | $423.9K | 14,069 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-01 | 2024-05-03 | 250 | $889.41 | $222.4K | 12,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 250 | $964.73 | $241.2K | 13,181 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-03-01 | 2024-03-05 | 358 | $967.50 | $346.4K | 13,431 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-05 | 2024-02-06 | 1,000 | $934.71 | $934.7K | 13,789 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-01 | 2024-02-02 | 273 | $945.61 | $258.2K | 14,789 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-01-02 | 2024-01-04 | 274 | $873.91 | $239.5K | 15,062 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-12 | 2023-12-14 | 5,105 | $856.71 | $4.37M | 15,336 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-11 | 2023-12-12 | 373 | $844.09 | $314.8K | 20,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-12-11 | 2023-12-12 | 270 | $838.44 | $226.4K | 20,814 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 7,649 | — | $0 | 7,649 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-08 | 2023-12-12 | 852 | $843.79 | $718.9K | 18,951 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-12-08 | 2023-12-12 | 2,133 | — | $0 | 21,084 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-11-01 | 2023-11-02 | 1,000 | — | $0 | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-11-01 | 2023-11-02 | 1,000 | $783.91 | $783.9K | 19,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-11-01 | 2023-11-02 | 1,000 | $381.40 | $381.4K | 20,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-10-02 | 2023-10-03 | 1,038 | — | $0 | 3,412 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-10-02 | 2023-10-03 | 1,038 | $372.46 | $386.6K | 20,841 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-10-02 | 2023-10-03 | 1,038 | $827.00 | $858.4K | 19,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-09-01 | 2023-09-06 | 250 | $834.55 | $208.6K | 19,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-01 | 2023-08-03 | 250 | $744.66 | $186.2K | 20,053 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-07-03 | 2023-07-06 | 250 | $710.09 | $177.5K | 20,303 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-06-01 | 2023-06-02 | 250 | $736.00 | $184.0K | 20,553 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-04-03 | 2023-04-05 | 1,100 | — | $0 | 4,450 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-04-03 | 2023-04-05 | 1,100 | $818.80 | $900.7K | 20,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-04-03 | 2023-04-05 | 1,100 | $372.46 | $409.7K | 21,903 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-03-01 | 2023-03-03 | 1,100 | — | $0 | 5,550 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-03-01 | 2023-03-03 | 1,100 | $372.46 | $409.7K | 21,903 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-03-01 | 2023-03-03 | 1,100 | $759.89 | $835.9K | 20,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-02-12 | 2023-02-14 | 1,276 | $751.78 | $959.3K | 20,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-02-07 | 2023-02-08 | 1,000 | — | $0 | 6,650 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-02-07 | 2023-02-08 | 1,000 | $769.04 | $769.0K | 22,079 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-02-07 | 2023-02-08 | 1,000 | $372.46 | $372.5K | 23,079 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-02-01 | 2023-02-03 | 1,100 | — | $0 | 7,650 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-02-01 | 2023-02-03 | 1,100 | $752.19 | $827.4K | 22,079 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-02-01 | 2023-02-03 | 1,100 | $372.46 | $409.7K | 23,179 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-01-03 | 2023-01-05 | 1,100 | — | $0 | 8,750 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-01-03 | 2023-01-05 | 1,100 | $372.46 | $409.7K | 23,179 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-01-03 | 2023-01-05 | 1,100 | $721.86 | $794.0K | 22,079 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-12-16 | 2022-12-20 | 10,971 | — | $0 | 10,971 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-12-16 | 2022-12-20 | 2,973 | — | $0 | 22,079 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-12 | 2022-12-13 | 264 | $730.17 | $192.8K | 19,106 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-12-09 | 2022-12-13 | 274 | $753.28 | $206.4K | 19,370 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-12-01 | 2022-12-02 | 1,100 | — | $0 | 9,850 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-12-01 | 2022-12-02 | 1,100 | $372.46 | $409.7K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-01 | 2022-12-02 | 1,100 | $756.19 | $831.8K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-11-04 | 2022-11-07 | 1,000 | — | $0 | 10,950 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-04 | 2022-11-07 | 1,000 | $727.82 | $727.8K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-11-04 | 2022-11-07 | 1,000 | $372.46 | $372.5K | 20,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-11-01 | 2022-11-02 | 1,100 | — | $0 | 11,950 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-01 | 2022-11-02 | 1,100 | $750.00 | $825.0K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-11-01 | 2022-11-02 | 1,100 | $372.46 | $409.7K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-10-03 | 2022-10-05 | 500 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-10-03 | 2022-10-05 | 600 | — | $0 | 13,050 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-10-03 | 2022-10-05 | 600 | $372.46 | $223.5K | 20,244 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-10-03 | 2022-10-05 | 500 | $342.93 | $171.5K | 20,144 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-10-03 | 2022-10-05 | 500 | $705.39 | $352.7K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-10-03 | 2022-10-05 | 600 | $705.39 | $423.2K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-01 | 2022-09-02 | 1,100 | — | $0 | 500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-01 | 2022-09-02 | 1,100 | $577.62 | $635.4K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-01 | 2022-09-02 | 1,100 | $342.93 | $377.2K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-08-01 | 2022-08-02 | 1,100 | — | $0 | 1,600 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-08-01 | 2022-08-02 | 1,100 | $581.53 | $639.7K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-08-01 | 2022-08-02 | 1,100 | $342.93 | $377.2K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-07-01 | 2022-07-05 | 1,100 | — | $0 | 2,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-07-01 | 2022-07-05 | 1,100 | $587.76 | $646.5K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-07-01 | 2022-07-05 | 1,100 | $342.93 | $377.2K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-06-01 | 2022-06-03 | 1,100 | — | $0 | 3,800 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-06-01 | 2022-06-03 | 1,100 | $342.93 | $377.2K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-06-01 | 2022-06-03 | 1,100 | $669.51 | $736.5K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-05-02 | 2022-05-03 | 1,100 | — | $0 | 4,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-05-02 | 2022-05-03 | 1,100 | $656.97 | $722.7K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-05-02 | 2022-05-03 | 1,100 | $342.93 | $377.2K | 20,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-04-01 | 2022-04-04 | 1,000 | — | $0 | 6,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 1,000 | $701.82 | $701.8K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-04-01 | 2022-04-04 | 1,000 | $342.93 | $342.9K | 20,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-01 | 2022-03-03 | 1,000 | — | $0 | 7,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-01 | 2022-03-03 | 1,000 | $615.39 | $615.4K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-01 | 2022-03-03 | 1,000 | $342.93 | $342.9K | 20,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-02-01 | 2022-02-02 | 1,000 | — | $0 | 8,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-01 | 2022-02-02 | 1,000 | $607.46 | $607.5K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-02-01 | 2022-02-02 | 1,000 | $342.93 | $342.9K | 20,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-01-03 | 2022-01-05 | 1,000 | — | $0 | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-05 | 1,000 | $625.00 | $625.0K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-01-03 | 2022-01-05 | 1,000 | $342.93 | $342.9K | 20,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-12-13 | 2021-12-14 | 344 | $653.12 | $224.7K | 19,644 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-12-11 | 2021-12-14 | 388 | $664.34 | $257.8K | 19,988 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-12-08 | 2021-12-10 | 14,253 | — | $0 | 14,253 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-12-08 | 2021-12-10 | 3,338 | — | $0 | 20,376 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-12-01 | 2021-12-02 | 1,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-12-01 | 2021-12-02 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-12-01 | 2021-12-02 | 1,000 | $639.13 | $639.1K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-11-01 | 2021-11-03 | 1,000 | — | $0 | 11,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-01 | 2021-11-03 | 1,000 | $640.00 | $640.0K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-11-01 | 2021-11-03 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-10-01 | 2021-10-04 | 1,000 | — | $0 | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-10-01 | 2021-10-04 | 1,000 | $576.75 | $576.8K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-10-01 | 2021-10-04 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-01 | 2021-09-03 | 1,000 | — | $0 | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-01 | 2021-09-03 | 1,000 | $674.72 | $674.7K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-01 | 2021-09-03 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-02 | 2021-08-04 | 1,000 | — | $0 | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-02 | 2021-08-04 | 1,000 | $577.12 | $577.1K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-02 | 2021-08-04 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-07-01 | 2021-07-02 | 1,000 | — | $0 | 15,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-07-01 | 2021-07-02 | 1,000 | $556.60 | $556.6K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-07-01 | 2021-07-02 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-06-07 | 2021-06-08 | 1,000 | — | $0 | 16,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-06-07 | 2021-06-08 | 1,000 | $511.65 | $511.6K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-06-07 | 2021-06-08 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-05-07 | 2021-05-10 | 1,000 | — | $0 | 17,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-05-07 | 2021-05-10 | 1,000 | $342.93 | $342.9K | 18,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-05-07 | 2021-05-10 | 1,000 | $495.63 | $495.6K | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-12-09 | 2020-12-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-12-09 | 2020-12-11 | 2,000 | — | $0 | 17,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-12-09 | 2020-12-11 | 1,075 | — | $0 | 15,038 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-10-05 | 2020-10-06 | 1,000 | — | $0 | 18,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-10-05 | 2020-10-06 | 1,000 | $342.93 | $342.9K | 14,963 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-10-05 | 2020-10-06 | 1,000 | $600.00 | $600.0K | 13,963 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-08-20 | 2020-10-06 | 1,000 | — | $0 | 19,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-08-20 | 2020-10-06 | 1,000 | $342.93 | $342.9K | 14,963 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-20 | 2020-10-06 | 1,000 | $612.15 | $612.1K | 13,963 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2019-12-11 | 2019-12-13 | 13,650 | — | $0 | 13,650 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2019-12-11 | 2019-12-13 | 1,463 | — | $0 | 13,963 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-12-12 | 2018-12-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2018-12-12 | 2018-12-14 | 10,000 | — | $0 | 12,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-07-02 | 2018-07-03 | 9,217 | $1.10 | $10.1K | 9,217 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-04-02 | 2018-04-04 | 11,800 | $0.86 | $10.1K | 11,800 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-02-12 | 2018-02-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2018-02-12 | 2018-02-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 19,989 | — | $0 | 19,989 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 6,831 | $1.48 | $10.1K | 6,831 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-10-02 | 2017-10-04 | 6,332 | — | $0 | 6,332 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-07-03 | 2017-07-05 | 8,511 | — | $0 | 8,511 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2017-04-07 | 2017-04-11 | 465,000 | — | $0 | 465,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-04-03 | 2017-04-04 | 5,878 | — | $0 | 5,878 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-03-29 | 2017-03-31 | 28,000 | — | $0 | 28,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-25 | 2017-01-27 | 34,144 | — | $0 | 34,144 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-25 | 2017-01-27 | 4,274 | — | $0 | 4,274 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 80,905 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer | 2016-09-28 | 2016-09-30 | 40,453 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 541 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-02-16 | 2016-02-17 | 80,905 | — | $0 | 80,905 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-02-03 | 2016-02-04 | 40,453 | — | $0 | 40,453 | SEC↗ |